During the past decade, Novant Health Cancer Institute - Wilkesboro conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 12 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Novant Health Cancer Institute - Wilkesboro" #1 sponsor was "National Cancer Institute (NCI)" with 14 trials, followed by "Alliance for Clinical Trials in Oncology" with 9 trials sponsored, "SWOG Cancer Research Network" with 8 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 2 trials sponsored and "Gynecologic Oncology Group" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Novant Health Cancer Institute - Wilkesboro" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "NRG Oncology" with 6 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Astellas Pharma US, Inc." with 1 trials as a collaborator and "Bayer" with 1 trials as a collaborator. Other collaborators include 3 different institutions and companies that were collaborators in the rest 13 trials.

According to Clinical.Site data, the most researched conditions in "Novant Health Cancer Institute - Wilkesboro" are "Invasive Breast Carcinoma" (3 trials), "Ovarian Seromucinous Carcinoma" (3 trials), "Recurrent Ovarian Carcinoma" (3 trials), "Stage IV Lung Cancer AJCC v8" (3 trials) and "Anatomic Stage II Breast Cancer AJCC v8" (2 trials). Many other conditions were trialed in "Novant Health Cancer Institute - Wilkesboro" in a lesser frequency.

Most popular intervention types in "Novant Health Cancer Institute - Wilkesboro" are "Drug" (31 trials), "Other" (26 trials), "Biological" (16 trials), "Procedure" (11 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Questionnaire Administration" (12 trials), "Computed Tomography" (6 trials), "Laboratory Biomarker Analysis" (6 trials) and "Nivolumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "Novant Health Cancer Institute - Wilkesboro" are 30 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Novant Health Cancer Institute - Wilkesboro". undefined are not yet recruiting, 9 are recruiting, 19 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Novant Health Cancer Institute - Wilkesboro, 2 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Novant Health Cancer Institute - Wilkesboro, 0 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".